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ABSTRACT 14 
In this work, the potential of the electrospraying technique to obtain food-grade gelatin 15 
capsules in the submicron range for sensitive bioactive protection was explored, 16 
studying the influence of the protein concentration on the size and morphology of the 17 
obtained particles. Gelatin was selected as encapsulating material because, being 18 
commonly used as a food ingredient, it possesses unique gelation properties and is 19 
commercially available at a low cost. The electrosprayed matrices were used to 20 
encapsulate a model antioxidant molecule, (Ð)-epigallocatechin gallate (EGCG). Very 21 
high encapsulation efficiencies, close to 100%, were achieved, and the antioxidant 22 
activity of the bioactive was fully retained upon encapsulation. The EGCG release 23 
profiles showed a delayed release of the encapsulated antioxidant in aqueous solutions. 24 
Furthermore, while free EGCG in PBS lost a 30% of their antioxidant activity being 25 
completely degraded in 100 hrs, encapsulated EGCG retained its whole antioxidant 26 
activity within this time period.  27 
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1. Introduction 37 
One of the main challenges in the development of functional foods is the preservation of 38 
the activity and bioavailability of the bioactive ingredients during food processing, 39 
storage and passage through the gastrointestinal tract. The development of edible nano- 40 
or microencapsulation matrices has been envisaged as a plausible option to protect these 41 
biologically active compounds against adverse conditions (Dube, Ng, Nicolazzo, & 42 
Larson, 2010a). There are a number of encapsulation techniques which can be used to 43 
produce nano- or microparticulate systems, being emulsification-evaporation, spray-44 
drying and coacervation the most extensively used (López-Rubio, Sanchez, 45 
Wilkanowicz, Sanz, & Lagaron, 2012). However, some of these production methods 46 
involve exposure of the bioactives to high temperatures and/or the use of organic 47 
solvents, factors which can affect the stability of sensitive nutrients and preclude their 48 
use for food applications due to toxicity concerns associated with the residual traces of 49 
solvents (López-Rubio & Lagaron, 2011). 50 
Electrospraying (e-spraying) has recently emerged as an alternative for the generation of 51 
polymeric particles incorporating bioactive agents (Bock, Dargaville, & Woodruff, 52 
2012) with application in therapeutics, cosmetics and the food industry (Jaworek & 53 
Sobczyk, 2008). E-spraying, together with electrospinning (e-spinning), are versatile 54 
electrohydrodynamic fabrication methods which can generate encapsulation structures 55 
in a one-step process (Chakraborty, Liao, Adler, & Leong, 2009) without the need of 56 
employing high temperatures or toxic solvents (López-Rubio & Lagaron, 2012). A 57 
polymer solution flowing out from a nozzle is subjected to an external electrical field in 58 
such a way that when the electrical forces overcome the forces of surface tension, a 59 
charged jet is ejected towards a grounded collector. During the flight, the jet is 60 
elongated and the solvent evaporates, producing dry continuous fibres in the case of e-61 
spinning (Bhardwaj & Kundu, 2010). In e-spraying, the jet breaks down into fine 62 
droplets which acquire spherical shapes due to the surface tension (Chakraborty et al., 63 
2009), subsequently producing solid nano- or microparticles upon solvent evaporation. 64 
Apart from the feasibility of working at mild ambient conditions and using food-grade 65 
solvents, e-spraying has many other advantages as compared to other encapsulation 66 
techniques, including high encapsulation efficiencies, uniform bioactive distribution in 67 
the matrix, ease of operation and industrial scalability (Bock et al., 2012; Chakraborty et 68 
al., 2009). Moreover, particles aggregation could be prevented due to their own mutual 69 
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electrical repulsion, and smaller droplet sizes than in conventional mechanical atomisers 70 
can be obtained (Jaworek et al., 2008).  71 
Among the different food-grade biopolymers which may be used as encapsulating 72 
materials, protein hydrogels are of particular interest as they are readily used as food 73 
ingredients, for instance to modify food texture or sensorial properties (Nieuwland et 74 
al., 2013). Specifically, gelatin has been widely employed for enhancing elasticity, 75 
stability and consistency of food products (Okutan, Terzi, & Altay, 2014). Moreover, it 76 
has been traditionally used by the pharmaceutical industry for the manufacture of hard 77 
and soft capsules to protect drugs from external agents such as atmospheric oxygen 78 
(Roussenova et al., 2012). Gelatin is obtained from partial hydrolysis of collagen which 79 
contains repeating sequences of glycine-aa1-aa2, where amino acids aa1 and aa2 are 80 
mainly proline and hydroxyproline (see Figure 1) (Lai, 2013). This biopolymer has 81 
drawn much research attention also in the field of controlled release of drugs due to its 82 
biodegradability and electrical properties, and because of its commercial availability 83 
and low cost (Lai, 2013; Okutan et al., 2014). One of the most interesting properties of 84 
gelatin is its ability to form thermoreversible hydrogels in water due to the formation of 85 
collagen-like triple helices, interconnected with amorphous regions of randomly coiled 86 
segments, and subsequent chains entanglement and network formation below the so-87 
called helixÐcoil transition temperature (Peña, de la Caba, Eceiza, Ruseckaite, & 88 
Mondragon, 2010; Strauss & Gibson, 2004). This characteristic of the polypeptide 89 
makes it ideal to be processed in aqueous media, while avoiding complete disruption of 90 
the obtained capsules when submerged in aqueous foods below its gel-sol transition 91 
temperature.  92 
However, gelatin cannot be e-sprayed at room temperature when dissolved in water 93 
(Huang, Zhang, Ramakrishna, & Lim, 2004) as gelation would occur (Erencia, Cano, 94 
Tornero, Macanás, & Carrillo, 2014). Different solvents, such as fluoroalcohols (Huang 95 
et al., 2004), have been suggested as alternatives to process gelatin by e-96 
spinning/spraying with positive results, but their high toxicity limits their use for food 97 
applications. The use of diluted carboxylic acids (Ki et al., 2005; Songchotikunpan, 98 
Tattiyakul, & Supaphol, 2008) or ethyl acetate (Song, Kim, & Kim, 2008) has also been 99 
proposed as non-toxic solvents in various works. Particularly, e-spinning of gelatin 100 
solutions in acetic acid has been previously reported for type B gelatin from bovine skin 101 
(Erencia et al., 2014; Okutan et al., 2014).  102 
5 
Green tea polyphenols are powerful antioxidants which have attracted great interest in 103 
the field of functional foods due to their numerous attributed health benefits. (Ð)-104 
Epigallocatechin gallate (EGCG), the most abundant and biologically active compound 105 
in green tea (Barras et al., 2009), was selected in this work as a model antioxidant 106 
molecule due to its numerous attributed health benefits. It has shown protective effects 107 
against infections (Steinmann, Buer, Pietschmann, & Steinmann, 2013), cardiovascular 108 
and neurodegenerative diseases (Fu et al., 2011), inflammation and arthritis (Singh, 109 
Akhtar, & Haqqi, 2010) and cancer (Larsen & Dashwood, 2009, 2010; Singh, Shankar, 110 
& Srivastava, 2011), among other therapeutic benefits. However, its poor stability in 111 
aqueous solutions (Dube, Nicolazzo, & Larson, 2010b; Li, Lim, & Kakuda, 2009) limits 112 
its direct addition to food products. Several carrier systems have been developed to 113 
protect EGCG from degradation (Barras et al., 2009; Dube et al., 2010b; Folch-Cano, 114 
Jullian, Speisky, & Olea-Azar, 2010; Li et al., 2009; Rocha et al., 2011; Ru, Yu, & 115 
Huang, 2010).  116 
In this work, for the first time, e-sprayed gelatin micro- and submicroparticles are 117 
proposed as food-grade encapsulating matrices for EGCG. A type A gelatin from 118 
porcine skin was selected in order to confirm whether previous results on the 119 
processability of bovine type B gelatin in diluted acetic acid could be applicable to a 120 
gelatin from a different origin. Thus, gelatin micro- and submicroparticles were 121 
produced in food-grade conditions by electrohydrodynamic treatment, and their ability 122 
for the encapsulation and stabilization of bioactives was studied using EGCG as a 123 
model water-soluble antioxidant. 124 
125 
INSERT FIGURE 1 ABOUT HERE 126 
127 
2. Materials and Methods 128 
2.1. Materials 129 
Type A gelatin from porcine skin (Gel), with reported gel strength of 175 g Bloom was 130 
obtained from Sigma-Aldrich. (Ð)-Epigallocatechin gallate (EGCG), 2,2-azino-bis(3-131 
ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS), buffer solutions of pH 132 
7.4 (phosphate buffered saline system, PBS) and pH 6.1 (2-(N-133 
morpholino)ethanesulfonic acid hemisodium salt, MES), potassium persulfate (K2O8S2) 134 
and potassium bromide FTIR grade (KBr) were also obtained from Sigma-Aldrich. 96% 135 
(v/v) acetic acid (Scharlab) and 96% (v/v) ethanol (Panreac) were used as received. 136 
6 
137 
2.2. Preparation of gelatin solutions 138 
Gelatin aqueous solutions of different concentrations, i.e. 5, 8, 10 and 20% (w/v), were 139 
prepared by dissolving the biopolymer in acetic acid 20% (v/v) at 40ºC under magnetic 140 
agitation, and cooled down to room temperature before processing. Gelation of the 141 
solutions was not observed for any of the samples. 142 
When EGCG was incorporated for its encapsulation, it was added to the gelatin 143 
solutions at room temperature under magnetic stirring, at a concentration of 10 wt.-% of 144 
the total solids content. 145 
146 
2.3. Characterization of the solutions 147 
The  surface  tension  of  the  solutions  was  measured  using  the  Wilhemy  plate  148 
method  in  an EasyDyne K20 tensiometer (Krüss GmbH, Hamburg, Germany) at room 149 
temperature. 150 
The electrical conductivity of the solutions was measured using a conductivity meter  151 
XS  Con6  (Labbox,  Barcelona,  Spain) at room temperature.  152 
The rheological behaviour of the solutions was studied using a rheometer model AR-G2 153 
(TA Instruments, USA), with a parallel plate geometry. The stainless steel plate 154 
diameter was 60 mm and the gap was fixed to 0.5 mm. The tests were performed at a 155 
controlled temperature of 25ºC ± 0.1ºC. Continuous shear rate ramps were performed 156 
from 0.1 to 200 s-1 during 15 min after equilibrating the samples for 5 min, and the 157 
shear stress of the samples was registered. All measurements were made at least in 158 
triplicate. 159 
160 
2.4. Electrohydrodynamic processing of the solutions 161 
The solutions were processed using a Fluidnatek LE-10 electrospinning/ 162 
electrospraying apparatus, equipped with a variable high voltage 0Ð30 kV power 163 
supply, purchased from BioInicia S.L. (Valencia, Spain). Solutions  were  introduced  in  164 
a  5  mL  plastic  syringe  and  were  pumped at a steady flow-rate through a stainless-165 
steel needle (0.9 mm of inner diameter). The needle was connected through a PTFE 166 
wire to the syringe, which was placed on a digitally controlled syringe pump. Processed 167 
samples were collected on a stainless-steel plate connected to the cathode of the power 168 
supply and placed horizontally with respect to the syringe. The processing parameters 169 
were empirically optimized for each gelatin concentration in order to attain stable 170 
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electrospraying avoiding dripping of the solution. Briefly, the flow rate varied from 0.15 171 
to 0.5 mL/h and the voltage was maintained within the range 15-28 kV. The distance 172 
between the tip of the syringe and the collector was 10 cm in all cases.173 
174 
2.5. Morphological characterization of the particles 175 
Scanning electron microscopy (SEM) was conducted on a Hitachi microscope (Hitachi 176 
S-4100) at an accelerating voltage of 10 kV and a working distance of 9-16 mm. 177 
Samples were sputter-coated with a gold-palladium mixture under vacuum prior to 178 
examination. Particle diameters were measured from the SEM micrographs in their 179 
original magnification using the ImageJ software. Size distributions were obtained from 180 
a minimum of 200 measurements.  181 
182 
2.6. Fourier transform infrared (FT-IR) analysis of the particles 183 
Empty and bioactive-containing capsules of ca. 1 mg were grounded and dispersed in 184 
130 mg of spectroscopic grade potassium bromide (KBr). A pellet was then formed by 185 
compressing the sample at ca. 150 MPa. FT-IR spectra were collected in transmission 186 
mode using a Bruker (Rheinstetten, Germany) FT-IR Tensor 37 equipment. The spectra 187 
were obtained by averaging 10 scans at 1 cm-1 resolution.  188 
189 
2.7. Encapsulation efficiency 190 
The encapsulation efficiency (EE) of the EGCG-loaded capsules was determined based 191 
on FT-IR absorbance measurements. A calibration curve (R2 = 0.995) was obtained 192 
using gelatin/EGCG mixtures of known relative concentrations (0, 5, 10 and 15 % w/w 193 
of EGCG). The relative maximum absorbances at 1409 cm-1 (corresponding to gelatin) 194 
and 1039 cm-1 (attributed to EGCG) were plotted against the EGCG concentration in the 195 
mixtures (cf. Figure S1 in the supplementary material). The EGCG content in the 196 
capsules was interpolated from the obtained linear calibration equation. The EE of the 197 
EGCG-loaded capsules was then calculated using Eq. (1): 198 
199 
    Eq. (1) 200 
201 
2.8. Thermal Properties of the particles 202 
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Thermogravimetric analysis (TGA) was performed with a TA Instruments model Q500 203 
TGA. The samples (ca. 8 mg) were heated from room temperature to 600ºC with a 204 
heating rate of 10ºC/min under dynamic air atmosphere. Derivative thermogravimetric 205 
(DTG) curves express the weight loss rate as a function of temperature. 206 
207 
2.9. EGCG release from the gelatin particles 208 
10 mg of gelatin/EGCG capsules were suspended in 20 mL of release medium and kept 209 
at 20ºC under agitation in a Selecta thermostatic bath model Unitronic Reciprocal C 210 
(Barcelona, Spain). Three different release media were used: ethanol (96% v/v), MES 211 
aqueous buffer (pH=6.1) and PBS aqueous buffer (pH=7.4). At different time intervals, 212 
the suspensions were centrifuged at 3500 rpm and ambient temperature during 10 min 213 
using a centrifuge from Labortechnik model Hermle Z 400 K (Wasserburg, Germany),214 
and 1 mL aliquot of the supernatant was removed for sample analysis. The aliquot 215 
volume was then replaced with fresh release medium and the particles re-suspended and 216 
left back in the thermostatic bath. 217 
The extracted aliquots were analysed by UV-Vis spectroscopy (Shanghai Spectrum 218 
model SP-2000UV, Shanghai, China) by measuring the absorbance at 274 nm 219 
(maximum of absorbance of EGCG (Rocha et al., 2011)). Calibration curves for EGCG 220 
quantification in solution by UV-Vis absorbance were previously obtained for the three 221 
different release media (R2ethanol = 0.998, R2MES = 0.999, R2PBS = 0.999). The EGCG 222 
release values were obtained from three independent experiments.  223 
224 
2.10. In-vitro antioxidant activity  225 
ABTS+ radical scavenging assay was performed in order to quantify the antioxidant 226 
activity of both free and encapsulated EGCG, following the decolourization assay 227 
protocol described by Re et al. (1999). Briefly, a stock solution of ABTS+ was prepared 228 
by reacting ABTS with potassium persulfate (7 and 2.45 mM in distilled water, 229 
respectively) and allowing the mixture to stand in the dark at room temperature for 24 230 
hrs. The ABTS+ stock solution was then diluted with acetic acid 20% v/v (same solvent 231 
in which the samples were dissolved) to an absorbance of 0.70±0.02 at 734 nm. Stock 232 
solutions of free and encapsulated EGCG (5 mM of EGCG in both cases) were prepared 233 
in acetic acid 20% v/v to facilitate the dissolution of the gelatin matrix and subsequent 234 
complete release of EGCG from the capsules. Then, these stock solutions were diluted 235 
20-fold. 10 L of diluted sample solution were added to 1 mL of diluted ABTS+, and 236 
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the absorbance at 734 nm measured at room temperature 1 min after initial mixing. The 237 
radical scavenging activity (RSA), expressed as the percentage of reduction of the 238 
absorbance at 734 nm after sample addition, was calculated using Eq. (2): 239 
240 
        Eq. (2) 241 
242 
Where A0 and A1 are the absorbances at 734 nm of ABTS+ before and 1 min after 243 
addition of the antioxidant samples, respectively.  244 
Experiments were performed on a Shanghai Spectrum spectrophotometer model SP-245 
2000UV (Shanghai, China), at least in triplicate. Solvent blanks were also run in each 246 
assay. Unloaded gelatin particles were also evaluated (same particle concentration as in 247 
loaded samples) to take into account the potential antioxidant activity of the 248 
encapsulation matrix. 249 
250 
2.11. EGCG degradation assays 251 
Solutions/suspensions of 5 mM EGCG and EGCG-loaded gelatin capsules with 252 
theoretical EGCG concentrations of 5 mM in PBS were prepared. After selected time 253 
intervals, the solutions/suspensions were diluted 20-fold with acetic acid 20% v/v and 254 
the ABTS+ radical scavenging assay was conducted as previously explained. The 255 
radical scavenging activity (RSA) at the different time intervals was calculated using eq. 256 
(2). 257 
258 
2.12. Statistical analysis 259 
A statistical analysis of experimental data was performed through analysis of variance 260 
(one-way ANOVA) using OriginPro 8 (OriginLab Corp., Northampton, USA). 261 
Homogeneous sample groups were obtained by using Fisher LSD test (95% significance 262 
level, p < 0.05).  263 
264 
3. Results and discussion 265 
3.1. Optimization of the e-spraying process for obtaining EGCG-loaded gelatin 266 
particles 267 
Gelatin solutions were prepared in diluted acetic acid (20% v/v) to enable their 268 
processing using e-spraying, as premature gelation of the protein precludes capsule 269 
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formation using this technique. Moreover, this solvent was considered appropriate for 270 
the expected final application as it does not leave toxic residues on the dry materials 271 
(Klossner, Queen, Coughlin, & Krause, 2008). Under these food-grade conditions, 272 
gelation of the solutions was not observed for any of the samples during the 273 
electrohydrodynamic processing at room temperature.274 
Different material morphologies can be obtained through electrohydrodynamic 275 
processing of polymer solutions depending on the process parameters and the solution 276 
properties. For food applications, particles rather than fibres are preferred, since they are 277 
easier to handle and to subsequently disperse within the food products. Therefore, 278 
various concentrations of gelatin were tested in order to optimize the e-spraying 279 
process, with the objective to obtain neat individual particles as free of residual fibrils as 280 
possible. Electrohydrodynamic processing of bovine type B gelatin solutions in acetic 281 
acid had been previously attempted (Erencia et al., 2014; Okutan et al., 2014), and the 282 
reported results served as a starting point to select a set of protein concentrations to be 283 
tested for the optimization of the e-spraying process for type A gelatin from porcine 284 
origin. Four different gelatin concentrations (5, 8, 10 and 20% w/v, with sample codes 285 
Gel5, Gel8, Gel10 and Gel20, respectively) were finally selected, and the processing 286 
parameters (i.e. flow rate and voltage) were also adjusted to maximize the production 287 
rate while keeping a stabilized jet, thus, avoiding dripping of the solution. The optimal 288 
processing parameters found in this study for the different compositions are summarized 289 
in Table 1.  290 
291 
INSERT TABLE 1 ABOUT HERE 292 
293 
The size and morphology of materials obtained through electrohydrodynamic 294 
processing is strongly dependent on the properties of the polymer solutions (Pérez-295 
Masiá, Lagaron, & López-Rubio, 2014). Thus, the selected gelatin solutions were 296 
characterized in terms of surface tension, electrical conductivity and rheological 297 
behaviour prior to their processing and the results are summarized in Figure 2. 298 
299 
INSERT FIGURE 2 ABOUT HERE 300 
301 
Figure 3 shows the morphology of the processed structures obtained from the different 302 
solutions together with the particle size distributions for the e-sprayed samples.  303 
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INSERT FIGURE 3 ABOUT HERE 304 
305 
Fibres were obtained for the sample with the greatest protein concentration (i.e. Gel20), 306 
while pseudo-spherical particles typical of the discontinuous e-spraying process, with 307 
more or less residual fibrils, were produced for lower gelatin concentrations. These 308 
results are consistent with the electrospinnability domains recently established by 309 
Erencia et al. (2014) for gelatin-water-acetic acid systems using a type B gelatin from 310 
bovine skin (Erencia et al., 2014). A certain protein concentration is needed to establish 311 
the necessary peptide chain entanglements and chain-chain interactions leading to fibre 312 
formation. The particle size distributions of the e-sprayed samples (cf. Figure 3) 313 
reflected a decrease in the particle diameter and greater heterogeneity of capsule sizes as 314 
the gelatin concentration decreased. In all cases, the majority of the particles had a size 315 
in the submicron range, having their maximum in the nanoscale. 316 
Regarding the solution properties, in general, a slight increase in the conductivity of the 317 
solutions was observed with the polymer concentration, whereas no significant variation 318 
was observed for their surface tension. Therefore, differences in the morphology of the 319 
processed materials could be mainly attributed to changes in the rheological properties 320 
of the solutions. All tested solutions exhibited a Newtonian behaviour, with a linear 321 
relationship between the shear stress and the shear rate in the whole range of study (cf. 322 
Figure 2) and, thus, the viscosity was calculated from the slope of the shear stress vs. 323 
shear rate curves. The Newtonian behaviour of gelatin in aqueous solutions, even at 324 
high concentrations, had been previously reported at neutral pH (Wulansari, Mitchell, 325 
Blanshard, & Paterson, 1998). As expected, the viscosity exponentially increased with 326 
the gelatin concentration (Erencia et al., 2014), which resulted in sample Gel20 having a 327 
viscosity considerably higher than the rest of the samples and above the so-called 328 
critical entanglement concentration, defined as the crossover of concentration from the 329 
semidilute unentangled to the semidilute entangled regimes in polymeric solutions 330 
(Gupta, Elkins, Long, & Wilkes, 2005). The presence of sufficient chain entanglements 331 
for a 20% gelatin concentration explains the production of e-spun fibres instead of e-332 
sprayed particles (Shenoy, Bates, Frisch, & Wnek, 2005) in sample Gel20, as jet 333 
fragmentation during processing was prevented by the strong intermolecular cohesion 334 
of this concentrated solution (Chakraborty et al., 2009).335 
The most spherical morphology, almost free of residual fibrils, was exhibited by Gel8. 336 
Higher concentrations led to fibrils formation while lower concentrations resulted in 337 
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some dripping of the solution. Hence, this gelatin concentration was selected as optimal 338 
for further experiments.  339 
Once the conditions for the production of e-sprayed gelatin capsules were optimized, 340 
these vehicles were loaded with EGCG as a model water-soluble antioxidant. The 341 
gelatin solution (8% w/v) was prepared as in previous experiments, and EGCG was 342 
subsequently added at room temperature to achieve a final theoretical EGCG 343 
concentration of 10% w/w in the capsules. The morphology and particle size 344 
distribution of the resulting encapsulates was similar to those of their unloaded 345 
counterparts (cf. Figure 3). A very similar morphology with slightly rougher surface of 346 
the capsules was observed for the loaded structures, as solution properties were not 347 
considerably affected upon EGCG addition (cf. Figure 2). 348 
349 
3.2. Molecular organization and encapsulation efficiency 350 
The e-sprayed gelatin capsules, both unloaded and loaded with EGCG, were 351 
characterized by FTIR spectroscopy along with the commercial untreated gelatin and 352 
EGCG.353 
The spectrum of commercial gelatin showed its four most characteristic bands centred at 354 
3430 cm-1 (Amide A, NH stretching), 1642 cm-1 (Amide I, C=O and CN stretching), 355 
1543 cm-1,(Amide II, N-H bending) and 1244 cm-1 (Amide III, C-N stretching) 356 
(Aewsiri, Benjakul, Visessanguan, Wierenga, & Gruppen, 2010; Gomes, Rodrigues, 357 
Martins, Henriques, & Silva, 2013; Li, Miao, Wu, Chen, & Zhang, 2014). Also, a band 358 
corresponding to the asymmetric stretching vibration of =CÐH and ÐNH3+ (Amide B) 359 
was observed at 3085 cm-1 (Nagarajan, Benjakul, Prodpran, Songtipya, & Nuthong, 360 
2013). The bands observed at 2960 and 2928 cm-1 correspond to CH2 asymmetric and 361 
symmetric stretching vibrations, respectively, mainly from the glycine backbone and 362 
proline side-chains (Nagarajan et al., 2013; Nagiah, Madhavi, Anitha, Srinivasan, & 363 
Sivagnanam, 2013). 364 
After the e-spraying treatment, sample Gel8 exhibited the same characteristic bands as 365 
the commercial gelatin, but a considerable narrowing and better definition of the bands 366 
was apparent, which has been previously observed for other biopolymers after capsule 367 
formation (Pérez-Masiá et al., 2014). Moreover, significant displacements were detected 368 
for the bands corresponding to the Amides A and I from 3430 and 1642 cm-1 to 3402 369 
and 1653 cm-1, respectively, which can be attributed to differences in hydrogen bonding 370 
and protein conformation (Nagarajan et al., 2013) caused by the e-spraying processing. 371 
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Specifically, shifts of the Amide A band to lower wavenumbers indicate hydrogen bond 372 
formation via the N-H groups of the peptides (Doyle, Bendit, & Blout, 1975), while the 373 
shift of the amide I band to 1653 cm-1 can be correlated with b-sheet peptide 374 
conformation as previously observed for other proteins (Ebrahimgol, Tavanai, 375 
Alihosseini, & Khayamian, 2014). 376 
The spectrum of commercial EGCG showed an intense band at 3358 cm-1 due to the 377 
stretching of O-H groups, and other characteristic bands at 1618 cm-1, attributed to the 378 
aromatic ring quadrant, at 1544, 1528 and 1518 cm-1, corresponding to the aromatic 379 
semicircle stretch, at 1294 cm-1, due to the deformation vibration of O-H groups of the 380 
aromatic alcohol, and at 1097 cm-1, owed to the aromatic rings stretch (Robb, Geldart, 381 
Seelenbinder, & Brown, 2002). The presence of EGCG in the loaded capsules was 382 
evidenced by the existence of absorption bands corresponding to this polyphenol in 383 
their infrared spectrum, in particular the bands at 1042 cm-1 (which shifted to 1038 cm-1384 
in the capsules) and 1148 cm-1 (cf. arrows in the inset of Figure 4).385 
Proteins have been described to strongly interact with polyphenol molecules through 386 
hydrogen bonding and hydrophobic interactions (Li et al., 2009; Peña et al., 2010). In 387 
the e-sprayed loaded gelatin particles developed in this work, apart from the 388 
displacement of the 1042 cm-1 band of the EGCG, other changes were observed in the 389 
infrared spectrum from gelatin upon encapsulation of the bioactive compound. For 390 
instance, the maximum of the Amide A band shifted to even lower wavenumbers (3358 391 
cm-1), thus suggesting, as previously explained, that hydrogen bonding between the 392 
gelatin matrix and the bioactive took place. The Amide III band also shifted from 1245 393 
cm-1 in Gel8 to 1241 cm-1 in the EGCG-loaded capsules. These differences suggest the 394 
presence of intermolecular interactions between the antioxidant and the biopolymer 395 
within the developed capsules, which might contribute to the stabilization of the former. 396 
397 
INSERT FIGURE 4 ABOUT HERE 398 
399 
Infrared spectroscopy was also used to estimate the encapsulation efficiency of the 400 
samples. Based on the measurements of absorbance intensities from the isolated spectral 401 
bands from the protein matrix and the bioactive at 1409 cm-1 and 1039 cm-1, 402 
respectively, a calibration curve (R2 = 0.995) was constructed using physical mixtures of 403 
gelatin and EGCG of known relative concentrations (cf. Figure S1 in the Supplementary 404 
data). The EE of the EGCG-loaded capsules was 96% ± 3%, i.e., almost all the 405 
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antioxidant added to the solution was effectively incorporated within the capsules. This 406 
value was considerably higher than those reported for other encapsulation systems for 407 
the protection of cathequins (Dube et al., 2010b; Fang, Hwang, Huang, & Fang, 2006; 408 
Hu, Ting, Zeng, & Huang, 2013; Shpigelman, Cohen, & Livney, 2012) and can be 409 
explained taking into account the great solubility of EGCG in the polymeric solution 410 
and the absence of partitioning effects (Dube et al., 2010b) when using e-spraying as the 411 
encapsulation technique.  412 
413 
3.3. TGA. Thermal stability of the particles.414 
Thermogravimetric analysis of raw materials and electrosprayed particles (Gel 8% w/v, 415 
both empty and EGCG-loaded), were performed in order to study possible 416 
thermostability changes of the ingredients upon electrohydrodynamic treatment. Table 2 417 
and Figure 5 summarize the main results. 418 
Three different stages were observed in the weight loss curve of gelatin. The first stage, 419 
observed at temperatures up to 200ºC, is related to the loss of adsorbed and bound water 420 
present in the gelatin samples due to its hygroscopic character. The second stage, 421 
corresponding to the major weight loss, occurred between 200 and 400°C and has been 422 
associated with the protein chain rupture and peptide bonds breakage (Inamura et al., 423 
2013). The last stage, observed between 400ºC and 600ºC, has been attributed to the 424 
thermal decomposition of the gelatin networks (Correia et al., 2013). Other authors 425 
relate these second and third stages to the elimination of aminoacid fragments in oxidant 426 
atmosphere, mainly proline, and the degradation of glycine, respectively (Aquino et al., 427 
2012). 428 
429 
INSERT TABLE 2 ABOUT HERE 430 
431 
The thermogravimetric curves of the e-sprayed gelatin particles showed similar 432 
degradation profiles to that of the original gelatin powder. However, slight changes in 433 
the degradation profile of the main stage were observed. The temperature of maximum 434 
degradation rate of this stage (Tmax1) increased upon e-spraying of the protein, both in 435 
the presence and in the absence of antioxidant, although degradation was extended over 436 
a wider range of temperatures. Specifically, a slight decrease in the onset temperature 437 
(Tonset) was observed, which cannot be ascribed to EGCG degradation as it was also 438 
seen for the unloaded structures. 439 
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440 
INSERT FIGURE 5 ABOUT HERE 441 
442 
Regarding the water loss during the first stage, noticeable differences were observed 443 
between unprocessed and e-sprayed gelatin samples. Different types of water bound to 444 
proteins have been reported (Correia et al., 2013), including absorbed and structural 445 
water. Absorbed water is removed from the samples up to 100ºC, while structural water 446 
needs more energy and is eliminated at higher temperatures. Figure 5 shows that, while 447 
the first weight loss stage of raw gelatin was extended up to 200ºC due to the presence 448 
of structural water, the water loss of e-sprayed gelatin samples, both loaded and 449 
unloaded, was only seen up to 100ºC, suggesting that only absorbed water was present 450 
in these samples. In fact, the weight loss in this first step was greater for raw gelatin 451 
(9.5%) than for both e-sprayed materials (7.2% for Gel8 and 6.0% for Gel8-EGCG). 452 
These findings support that the fast drying of the samples during electrohydrodynamic 453 
processing of gelatin solutions is capable of removing structural water from the protein, 454 
and promoting hydrogen bonding between polypeptide chains and also between the 455 
protein and the polyphenol molecules as observed by infrared spectroscopy.      456 
No peaks attributed to the degradation of EGCG were detected in the TGA curve of the 457 
EGCG-loaded capsules. This could be explained by the good compatibility and 458 
intermolecular interactions between the polymer and the bioactive, as previously 459 
inferred from the infrared results, which contributed to the stabilization of the latter until 460 
the protecting matrix was degraded. 461 
462 
3.4. EGCG release from the electrosprayed gelatin particles 463 
The release of EGCG from the e-sprayed gelatin capsules was studied in three different 464 
media. PBS aqueous buffer (pH=7.4) was selected as a simulated biological fluid, as it 465 
is one of the most commonly used blood plasma simulant (Singh, Sharma, & 466 
Majumdar, 2013). On the other hand, ethanol is a good simulant for fatty foods and it is 467 
easy to work with analytically (Baner, Bieber, Figge, Franz, & Piringer, 1992; Cooper, 468 
Goodson, & O'Brien, 1998), so it was selected as a fatty food simulant, while MES 469 
aqueous buffer (pH=6.1) was selected as a simulant for slightly acidic aqueous foods 470 
such as juices (Tola & Ramaswamy, 2014). 471 
The resulting release profiles are depicted in Figure 6. An initial burst release was 472 
observed in all tested media, followed by a slower sustained release which was more 473 
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clearly observed in the ethanolic suspension. The release was faster in aqueous media as 474 
a consequence of the swelling of the gelatin matrix, but still, due to the encapsulation of 475 
the antioxidant molecule its dissolution in these media was delayed. This will 476 
consequently impact on the degradation kinetics in solution. 477 
478 
INSERT FIGURE 6 ABOUT HERE 479 
480 
A number of semi-empirical mathematical models have been proposed in the literature 481 
to describe the release kinetics of bioactive molecules from a carrier or delivery system 482 
(Siepmann & Peppas, 2012), and some of the most commonly used ones have been 483 
applied to the experimental data in Figure 6, including the Higuchi equation (Higuchi, 484 
1961), the power law model or Ritger-Peppas semiempirical equation (Ritger & Peppas, 485 
1987), and the Peppas-Sahlin model (Peppas & Sahlin, 1989). The last two take into 486 
account the combination of Fickian (diffusion) and non-Fickian (polymer relaxation) 487 
release mechanisms. These models usually fit experimental data only in the early time 488 
points of the release profile (Ritger et al., 1987), and thus only the data corresponding to 489 
the so called burst release phase (Gallagher & Corrigan, 2000) was fitted to the 490 
models. 491 
The Peppas-Sahlin model was the one which better fitted our experimental data. Its 492 
general equation is shown in Eq. (3), where Mt is the mass of EGCG released at time t, 493 
M0 is the total mass of EGCG loaded in the particles, m is the Fickian diffusional 494 
exponent, and ki are kinetic constants (Siepmann et al., 2012). For an aspect ratio of 1 495 
(i.e. spherical geometry of the carrier), m = 0.425 (Peppas et al., 1989). Table 3 shows 496 
the EGCG release kinetic parameters for the Peppas-Sahlin equation in the different 497 
food simulants. 498 
499 
        Eq. (3) 500 
501 
INSERT TABLE 3 ABOUT HERE 502 
503 
The Peppas-Sahlin model allows estimation of the relative contribution of the 504 
relaxational phenomenon and the diffusional mechanism on the release kinetics. The 505 
first term of the equation ( ) accounts for the contribution of the diffusion 506 
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phenomenon to the EGCG release kinetics, while the second term ) accounts 507 
for the case-II transport (Peppas et al., 1989; Spizzirri et al., 2013). For the e-sprayed 508 
gelatin particles, k1 was greater than k2 in the three food simulants, suggesting that the 509 
diffusional mechanism was predominant. Similar behavior has been reported for other 510 
spherical carriers based on gelatin microgels (Spizzirri et al., 2013). The ratio k1/k2 was 511 
higher for the release of EGCG in ethanol than in the aqueous media, indicating that the 512 
swelling or relaxation of the gelatin matrix had a greater contribution to the release 513 
kinetics in the aqueous food simulants, as expected. Moreover, the release was also 514 
much faster in these media, as confirmed by the higher values of the kinetic constants in 515 
MES and PBS. 516 
517 
3.5. In-vitro antioxidant activity and degradation assays 518 
ABTS+ decolourization assay was performed in order to compare the antioxidant 519 
activity of encapsulated and free EGCG. For this purpose, diluted acetic acid was used 520 
to disrupt the gelatin capsules and dissolve EGCG. The concentration of loaded 521 
capsules was calculated to have the same EGCG concentration as in the free EGCG 522 
sample (i.e. 0.25 mM), assuming 100% encapsulation efficiency. Unloaded e-sprayed 523 
gelatin particles were also evaluated in order to disregard possible contributions of the 524 
encapsulating matrix to the total antioxidant activity of the encapsulates, using the same 525 
particles concentration as for the loaded capsules. Solvent blanks were run too. The 526 
radical scavenging activity (RSA) of each antioxidant solution was calculated using eq. 527 
(2). 528 
No statistically significant differences (p < 0.05) were observed between the inhibition 529 
of the absorbance caused by the e-sprayed gelatin matrix (RSA = 3.2 ± 0.2 %) and the 530 
solvent blank (RSA= 3.4 ± 0.2 %), so the whole antioxidant activity of the loaded 531 
capsules could be attributed to its EGCG content. The antioxidant activity of 532 
encapsulated EGCG (RSA = 26.8 ± 0.7 %) was not significantly different from that of 533 
free EGCG (RSA = 27.2 ± 1.5 %) either, thus confirming that the encapsulation 534 
efficiency was indeed very close to 100%, because the theoretical loading matched the 535 
experimental antioxidant activity of free EGCG. These results corroborated the previous 536 
estimations obtained from infrared spectroscopy measurements and verified that the e-537 
spraying process did not damage the bioactive, as its antioxidant activity was kept 538 
intact. 539 
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The ABTS+ decolourization assay was also used to study the degradation of free and 540 
encapsulated EGCG in aqueous solution/suspension, by measuring the decrease in their 541 
RSA value with time as an indicative of the loss of their antioxidant activity due to 542 
degradation. PBS was the selected degradation media as EGCG is highly unstable in 543 
aqueous solution, especially in neutral or alkaline solutions (Barras et al., 2009; Li et al., 544 
2009), suffering degradation through oxidative processes (Dube et al., 2010b). Hence, 545 
solutions 5 mM of EGCG and suspensions of EGCG-loaded capsules with the same 546 
theoretical EGCG concentration were prepared. Fast degradation of EGCG upon 547 
dissolution in PBS media could be clearly observed by its gradual transition from a light 548 
pink to an intense yellowish colour. At selected time intervals, the solutions/suspensions 549 
were diluted 20-fold with acetic acid 20% v/v with the double objective of disrupting 550 
the gelatin capsules and stopping the degradation process by acidification of the 551 
medium. The inhibition of the absorbance of ABTS+ caused by the resulting solutions 552 
was measured and their RSA values calculated. The results are shown in Figure 7.     553 
554 
INSERT FIGURE 7 ABOUT HERE 555 
556 
The free EGCG samples lost a 30% of their initial RSA in 100 hrs. No further 557 
antioxidant activity loss was observed after longer time periods, suggesting that EGCG 558 
was fully degraded in PBS after 4 days, even though its degradation products also 559 
exhibited some antioxidant activity. In contrast, no significant loss of antioxidant 560 
activity was observed for the encapsulated molecule within an observation time of 10 561 
days (p < 0.05). This finding proved that the encapsulation system proposed in this 562 
work was capable of protecting EGCG from degradation in slightly alkaline solutions. 563 
564 
1. Conclusions 565 
Gelatin-based encapsulation matrices were produced from food-grade ingredients 566 
without the need of employing high temperatures or toxic solvents by 567 
electrohydrodynamic treatment of gelatin solutions in diluted acetic acid. The 568 
electrospraying process was initially optimized in order to obtain neat particles, almost 569 
free of fibrils, to facilitate handling and dispersion into food products. Pseudo-spherical 570 
particles with mean sizes in the submicron range were obtained. The potential of these 571 
particles to be used as edible carriers for the encapsulation and protection of a model, 572 
water-soluble antioxidant, EGCG, was tested by producing electrosprayed gelatin 573 
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particles with a theoretical antioxidant loading of 10% w/w. Infrared spectroscopy and 574 
ABTS+ assays revealed that the encapsulation efficiency of the system was very close 575 
to 100%, much higher than that reported for other encapsulation systems for the 576 
protection of catechins. Moreover, the radical scavenging assays proved that 577 
encapsulation by the e-spraying technique did not damage the bioactive compound, as it 578 
retained its antioxidant activity intact. Additionally, this work also proved that the 579 
obtained gelatin capsules were capable of stabilizing EGCG against degradation in 580 
aqueous solution (pH = 7.4), as its antioxidant activity was better preserved in this 581 
media when encapsulated than in its free form. This stabilization can be attributed to 582 
both the delay of its dissolution in aqueous media, as observed in the in-vitro EGCG 583 
release assays, and to the intermolecular interactions which were established between 584 
the active molecule and its encapsulating matrix. The overall results presented in this 585 
work demonstrate, for the first time, the potential of electrosprayed gelatin particles to 586 
be used as encapsulation matrices for polyphenols with application in the development 587 
of functional foods.       588 
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Table 1. Gelatin concentrations tested and their optimal processing parameters. 775 
776 
777 
778 
779 
780 
781 
Sample Code [Gelatin]  (% w/v) Flow rate (mL/h) Voltage (kV)
Gel20 20 0.15 28
Gel10 10 0.5 20
Gel8 8 0.2 15
Gel5 5 0.2 17
26 
Table 2. Onset temperature, temperatures of maximum degradation rate and 782 
corresponding weight losses of the two degradation stages for unprocessed EGCG and 783 
gelatin, and for the e-sprayed particles784 
Sample Tonset (ºC) Tmax1a (ºC) WL1b (%) Tmax2a (ºC) WL2b
Gelatin 265.6 301.3 45.2 537.7 36.9
EGCG 228.8 235.4 33.7 483.9 62.3
Gel8 241.3 324.4 53.7 531.8 34.5
Gel8-EGCG 235.8 321.6 50.2 534.4 37.0
a Temperature of maximum degradation rate 785 
b Weight loss of the corresponding degradation stage 786 
787 
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Table 3. EGCG release kinetic parameters (ki) and the linear correlation coefficients 788 
(R2) 789 
790 
791 
792 
793 
794 
795 
796 
Release medium k1 (h-0.425) k2 (h-0.850) R2
Ethanol 96% 0.10±0.01 -0.006±0.002 0.98
MES 0.42±0.02 -0.053±0.006 0.99
PBS 0.35±0.04 -0.043±0.007 0.95
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Figure captions 797 
Figure 1. Schematic chemical structures of raw materials: a) gelatin and b) EGCG 798 
Figure 2. Electrical conductivity, surface tension and rheological behaviour of gelatin 799 
solutions in diluted acetic acid (20% v/v). Properties of gelatin solution containing 800 
EGCG are also shown (emphasised by arrows).  801 
Figure 3. SEM images of gelatin structures obtained through electrohydrodynamic 802 
processing of aqueous solutions with different protein concentrations (left) and particle 803 
size distributions for the e-sprayed samples (right). The image and size distribution at 804 
the bottom correspond to EGCG-loaded capsules. Scale bars in SEM images correspond 805 
to 2 µm. Asterisk (*) depicts significant differences for the particle size distribution (p < 806 
0.05). 807 
Figure 4. Infrared spectra of commercial and e-sprayed materials in the region from 808 
1800 to 800 cm-1. Arrows indicate bands corresponding to EGCG. The whole spectra 809 
are depicted in the inset, where arrows indicate band displacements.810 
Figure 5. DTG curves of raw EGCG and gelatin, and e-sprayed particles 811 
Figure 6. EGCG release profiles from e-sprayed gelatin particles in a) ethanol, b) MES 812 
and c) PBS  813 
Figure 7. Degradation profiles of free and encapsulated EGCG in PBS. Asterisk (*) 814 
depicts significant differences between the two samples at each time point (p < 0.05). 815 
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FIGURE 6. 833 
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FIGURE 7. 836 
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Highlights 838 
839 
 Gelatin capsules were obtained through electropraying for bioactive protection 840 
841 
 (–)-Epigallocatechin gallate (EGCG) was encapsulated in the electrosprayed capsules 842 
843 
 Encapsulation efficiencies close to 100% were achieved 844 
845 
 The antioxidant activity of the bioactive was kept during electrospraying  846 
847 
 Electrosprayed gelatin capsules effectively protected EGCG against degradation 848 
849 
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Supplementary Material 850 
851 
852 
853 
854 
Figure S1. FTIR spectra of KBr pellets used for the calibration curve containing 855 
different proportions of gelatin and EGCG (left) and the corresponding calibration curve 856 
(right). The spectrum from the EGCG-containing capsules is also included. Arrows 857 
point out the intensity changes of the selected bands. 858 
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